[go: up one dir, main page]

ECSP077208A - Inhibidores de los canales de potasio - Google Patents

Inhibidores de los canales de potasio

Info

Publication number
ECSP077208A
ECSP077208A EC2007007208A ECSP077208A ECSP077208A EC SP077208 A ECSP077208 A EC SP077208A EC 2007007208 A EC2007007208 A EC 2007007208A EC SP077208 A ECSP077208 A EC SP077208A EC SP077208 A ECSP077208 A EC SP077208A
Authority
EC
Ecuador
Prior art keywords
potassium channel
channel inhibitors
inhibitors
compounds
relates
Prior art date
Application number
EC2007007208A
Other languages
English (en)
Inventor
Mark T Bilodeau
Zhicai Wu
John Hartnett
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ECSP077208A publication Critical patent/ECSP077208A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a compuestos que tienen la estructura útiles como inhibidores del canal de potasio para tratar arritmias cardíacas y afecciones similares.
EC2007007208A 2004-07-29 2007-01-26 Inhibidores de los canales de potasio ECSP077208A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29

Publications (1)

Publication Number Publication Date
ECSP077208A true ECSP077208A (es) 2007-02-28

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007208A ECSP077208A (es) 2004-07-29 2007-01-26 Inhibidores de los canales de potasio

Country Status (15)

Country Link
KR (1) KR20070043985A (es)
AR (1) AR049847A1 (es)
BR (1) BRPI0513793A (es)
CR (1) CR8876A (es)
EC (1) ECSP077208A (es)
IL (1) IL180846A0 (es)
MA (1) MA28980B1 (es)
MX (1) MX2007001188A (es)
NO (1) NO20071107L (es)
PE (1) PE20060382A1 (es)
RU (1) RU2344134C2 (es)
TW (1) TW200607493A (es)
UA (1) UA88018C2 (es)
WO (1) WO2006028590A1 (es)
ZA (1) ZA200700477B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012520829A (ja) * 2009-03-18 2012-09-10 メディキュア・インターナショナル・インコーポレーテッド チロフィバンの経皮用医薬製剤および投与
AU2013274619B2 (en) 2012-06-11 2017-09-28 Bristol-Myers Squibb Company Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1465863B1 (en) * 2002-01-04 2008-07-09 NeuroSearch A/S Potassium channel modulators

Also Published As

Publication number Publication date
PE20060382A1 (es) 2006-05-15
WO2006028590A1 (en) 2006-03-16
ZA200700477B (en) 2009-08-26
BRPI0513793A (pt) 2008-05-13
AR049847A1 (es) 2006-09-06
TW200607493A (en) 2006-03-01
MX2007001188A (es) 2007-03-21
RU2007107408A (ru) 2008-09-10
KR20070043985A (ko) 2007-04-26
NO20071107L (no) 2007-04-19
MA28980B1 (fr) 2007-11-01
RU2344134C2 (ru) 2009-01-20
UA88018C2 (ru) 2009-09-10
IL180846A0 (en) 2007-06-03
CR8876A (es) 2007-08-28

Similar Documents

Publication Publication Date Title
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
UY32730A (es) Inhibidores de cyp17
DOP2010000225A (es) Arilpirrolinas insecticidas
CO6511220A2 (es) Quinazolinas como inhibidores de los canales iónicos de potasio
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
ATE510822T1 (de) Kaliumkanalinhibitoren
PA8667201A1 (es) Nuevos compuestos farmaceuticos
GT201200339A (es) Compuestos, composiciones de tioacetato y mètodos de uso
CO6430459A2 (es) Derivados de prolina como inhibidores de catepsina
UY31562A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
DOP2011000134A (es) Lactamas como inhibidores de beta secretasa
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
CO6361894A2 (es) Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa
UY29668A1 (es) Nuevos derivados de heptaazafenaleno, procedimientos para su obtencinn, ase como utilizacinn de estos como agentes protectores contra la radicacinn uv.-
CR10029A (es) Combinacion de productos activos fungicidas
ECSP099738A (es) Derivados de pirazolona como inhibidores de pde4
EA201170201A1 (ru) Предотвращение и лечение радиационного поражения
ECSP077208A (es) Inhibidores de los canales de potasio
CO7170170A2 (es) Derivados de oxazolidinona 3,4-disustituidos y su uso como inhibidores del canal de potasio activado por calcio
CR10228A (es) Asociacion entre un antiaterotrombotico y un inhibidor de la enzima de conversion de la angiotensina
UY30974A1 (es) Metodo para tratar el dolor mediado por los receptores de cb2 (ii)
DOP2005000144A (es) Inhibidores de los canales de potasio
ECSP088994A (es) INHIBIDORES DE CANAL DE POTASIO Kv1.5